Varex Imaging (NASDAQ:VREX) Updates Q1 2025 Earnings Guidance

Varex Imaging (NASDAQ:VREX) issued an update on its first quarter 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of -0.050-0.100 for the period, compared to the consensus EPS estimate of 0.040. The company issued revenue guidance of $195.0 million-$215.0 million, compared to the consensus revenue estimate of $189.4 million. Varex Imaging also updated its Q1 guidance to $(0.05)-$0.10 EPS.

Varex Imaging Stock Performance

NASDAQ VREX traded up $0.44 on Tuesday, reaching $14.56. 1,277,780 shares of the stock were exchanged, compared to its average volume of 489,539. The company has a current ratio of 3.34, a quick ratio of 1.89 and a debt-to-equity ratio of 0.67. Varex Imaging has a one year low of $10.19 and a one year high of $21.50. The firm has a market capitalization of $595.50 million, a PE ratio of 19.89 and a beta of 0.53. The company’s 50-day simple moving average is $12.35 and its two-hundred day simple moving average is $13.46.

Analysts Set New Price Targets

Separately, B. Riley initiated coverage on shares of Varex Imaging in a research note on Friday, August 23rd. They set a “buy” rating and a $21.00 target price on the stock.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.